Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 24, 2008
Equipotent doses to switch from high doses of opioids to transdermal buprenorphineSebastiano Mercadante, Alessandra Casuccio, Walter Tirelli, et al.
The Clinical Journal of Pain|December 23, 2009
When the progression of disease lowers opioid requirement in cancer patientsSebastiano Mercadante, Patrizia Ferrera, Loriana Di Emidio, et al.
BMJ Supportive & Palliative Care|December 23, 2020
Aberrant opioid use behaviour in advanced cancerSebastiano Mercadante, Claudio Adile, Walter Tirelli, et al.
Pain Practice : the Official Journal of World Institute of Pain|November 17, 2020
Barriers and Adherence to Pain Management in Advanced Cancer PatientsSebastiano Mercadante, Claudio Adile, Walter Tirelli, et al.
The Clinical Journal of Pain|October 26, 2010
Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled studySebastiano Mercadante, Walter Tirelli, Fabrizio David, et al.
Clinical Therapeutics|November 20, 2009
Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: a 4-week, nonrandomized, open-label, uncontrolled observational studySebastiano Mercadante, Gianpiero Porzio, Patrizia Ferrera, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 13, 2005
Randomized double-blind, double-dummy crossover clinical trial of oral tramadol versus rectal tramadol administration in opioid-naive cancer patients with painSebastiano Mercadante, Edoardo Arcuri, Flavio Fusco, et al.
Journal of Pain and Symptom Management|March 28, 2006
Low morphine doses in opioid-naive cancer patients with painSebastiano Mercadante, Gianpiero Porzio, Patrizia Ferrera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study GroupAugusto Caraceni, Ernesto Zecca, Cesare Bonezzi, et al.
Pageof 1